Juvenile myelomonocytic leukemia: Molecular understanding and prospects for therapy

Molecular Medicine Today

Volumn 2, Issue 11, 1996, Pages 468-475

  Emanuel, Peter D ^a   Shannon, Kevin M ^a   Castleberry, Robert P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFIBROMIN; PROTEIN; RAS PROTEIN;

CHRONIC MYELOMONOCYTIC LEUKEMIA; FORECASTING; HUMAN; HYPERSENSITIVITY; METABOLISM; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; SYNDROME;

FORECASTING; HUMANS; HYPERSENSITIVITY; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; NEUROFIBROMIN 1; PROTEINS; RAS PROTEINS; SIGNAL TRANSDUCTION; SYNDROME;

EID: 0030280090     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/1357-4310(96)10044-7     Document Type: Review

References (40)

1. Altman, A.J. (1993) Chronic leukemias of childhood, in Principles and Practice of Pediatric Oncology (Pizzo, P.A. and Poplack, D.G., eds), pp. 501-518, J.B. Lippincott
2. Altman, A.J., Palmer, C.G. and Baehner, R.L. (1974) Juvenile 'chronic granulocytic leukemia': A panmyelopathy with prominent monocytic involvement and circulating monocyte colony-forming cells, Blood 43, 341-350
3. Castro-Malaspina, H. et al. (1984) Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factors, Cancer 54, 675-686
4. Estrov, Z., Grunberger, T., Chan, H.S.L. and Freedman, M.H. (1986) Juvenile chronic myelogenous leukemia: characterization of the disease using cell cultures, Blood 67, 1382-1387
5. Luna-Fineman, S., Shannon, K.M. and Lange, B.J. (1995) Childhood monosomy 7: epidemiology, biology and mechanistic implications, Blood 85, 1985-1999
6. Herrod, H.G., Dow, L.W. and Sullivan, J.L. (1983) Persistent Epstein-Barr virus infection mimicking juvenile chronic myelogenous leukemia: immunologic and hematologic studies, Blood 61, 1098-1104
7. Kirby, M.A., Weitzman, S. and Freedman, M.H. (1990) Juvenile chronic myelogenous leukemia: differentiation from infantile cytomegalovirus infection, Am. J. Pediatr. Hematol. Oncol. 12, 292-296
8. Busque, L. et al. (1995) Clonality in juvenile chronic myelogenous leukemia, Blood 85, 21-30
9. Bagby, G.C., Jr et al. (1988) Interleukin 1-dependent paracrine granulopoiesis in chronic granulocytic leukemia of the juvenile type, J. Clin. Invest. 82, 143-146
10. Freedman, M.H. et al. (1992) Central role of tumor necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukemia, Br. J. Haematol. 80, 40-48
11. Emanuel, P.D. et al. (1991) The role of monoeyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia, Exp. Hematol. 19, 1017-1024
12. Emanuel, P.D. et al. (1991) Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors, Blood 77, 925-929
13. + cells in vitro and in vivo using SCID mouse assays, Blood 82 (Suppl. 1), 197a
14. + purified cells in juvenile and adult chronic myelomonocytic leukemia: effect of retinoids, Blood 86 (Suppl. 1), 791a
15. Wagner, J.E. et al. (1992) Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment, Blood 79, 1874-1881
16. Prchal, J.F. and Axelrad, A.A. (1974) Bone-marrow responses in polycythemia vera, New Engl. J. Med. 290, 1382
17. Dai, C.H. et al. (1991) Polycythemia vera blood burst-forming units-erythroid are hypersensitive to interleukin-3, J. Clin. Invest. 87, 391-396
18. Correa, P.N., Eskinazi, D. and Axelrad, A.A. (1994) Circulating erythroid progenitors in polycythemia vera are hypersensitive to insulin-like growth factor-1 in vitro: studies in an improved serum-free medium, Blood 83, 99-112
19. Prchal, J.T. et al. (1985) Autosomal dominant polycythemia, Blood 66, 1208-1214
20. Emanuel, P.D., Zhu, S-W., Bates, L.J. and Zuckeiman, K.S. (1991) Hypersensitivity to hemopoietic growth factors in chronic myelomonocytic leukemia (CMML), Blood 78 (Suppl. 1), 156a
21. + cells, Blood 86 (Suppl. 1), 48a
22. Taylor, K. et al. (1995) Inappropriate elevation and loss of feedback regulation of thrombopoietin in essential thrombocythaemia (ET), Blood 86 (Suppl. 1), 49a
23. Prchal, J.T. and Prchal, J.F. (1994) Evolving understanding of the cellular defect in polycythemia vera: implications for its clinical diagnosis and molecular pathophysiology. Blood 83, 1-4
24. Bourne, H.R., Sanders, D.A. and McCormick, F. (1990) The GTPase superfamily: a conserved switch for diverse cell functions, Nature 348, 125-132
25. Satoh, T., Nakafuku, M, Miyajima, A. and Kaziro, Y. (1991) Involvement of ras p21 protein in signal transduction pathways from interleukin 2, interleukin 3, and granulocyte/macrophage colony-stimulating factor, but not from interleukin 4, Proc. Natl. Acad. Sci. U. S. A. 88, 3314-3318
26. Bos, J.L. (1989) ras oncogenes in human cancer: a review, Cancer Res. 49, 4682-4689
27. Miyauchi, J. et al. (1994) Mutations of the N-ras gene in juvenile chronic myelogenous leukemia, Blood 83, 2248-2254
28. Boguski, M.S. and McCormick, F. (1993) Proteins regulating Ras and its relatives, Nature 366, 643-654
29. Bader, J.L. and Miller, R.W. (1978) Neurofibromatosis and childhood leukemias, J. Pediatr. 92, 925-929
30. ras, Blood 84, 3435-3439
31. Brodeur, G.M. (1994) The NF1 gene in myelopoiesis and childhood myelodys-plastic syndromes, New Engl. J. Med. 330, 637-639
32. Shannon, K.M. et al. (1994) Loss of the normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders, New Engl. J. Med. 330, 597-601
33. Bollag, G. et al. (1996) Loss of NF1 results in activation of the Ras signalling pathway and leads to aberrant growth in haematopoietic cells, Nat. Genet. 12, 144-148
34. Largaespada, D.A. et al. (1996) Nf1 deficiency causes Ras mediated granulocyte/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukemia, Nat. Genet. 12, 137-143
35. Lilleyman, J.S., Harrison, J.F. and Black, J.A. (1977) Treatment of juvenile chronic myeloid leukemia with sequential subcutaneous cytarabine and oral mercaptopurine, Blood 49, 559-562
36. Chan, H.S., Estrov, Z., Weitzman, S.S. and Freedman, M.H. (1987) The value of intensive combination chemotherapy for juvenile chronic myelogenous leukemia, J Clin. Oncol. 5, 1960-1967
37. Smith, F.O. et al. (1994) Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia, Blood 84 (Suppl. 1), 201a
38. Passmore, S.J. et al. (1995) Pediatric myelodysplasia: a study of 68 children and a new prognostic scoring system, Blood 85, 1742-1750
39. Castleberry, R.P. et al. (1994) A pilot study of isoretinoin in the treatment of juvenile chronic myelogenous leukemia, New Engl. J. Med. 331, 1680-1684
40. Gibbs, J.B., Oliff, A. and Kohl, N.B. (1994) Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic, Cell 77, 175-178